PF4/肝素-ELISA光密度定量预测血小板活化性VITT抗体的解读
该队列研究系统评估疑似VITT样本的半定量PF4/肝素-ELISA光密度与PF4诱导血小板活化试验的关系,发现光密度越高,血小板活化试验阳性概率越大;61份光密度>1.0但活化试验阴性的血清经1/4至1/10稀释后27份(44.3%)转为阳性,提示稀释可提高VITT抗体血小板活化试验的阳性检出。
要点
- 疑似VITT血清的PF4/肝素-ELISA光密度越高,血小板活化试验阳性概率越大。
- 光密度>1.0但活化试验阴性的61份血清中,1/4至1/10稀释后27份(44.3%)转为阳性。
- VITT血清学与HIT相似,但VITT血清稀释可提高血小板活化试验阳性概率。
核心结论
- VITT血清学与HIT相似,ELISA光密度越高,血小板活化抗体检测阳性概率越高。
- 与HIT抗体不同,稀释疑似VITT血清可提高血小板活化试验阳性概率,提示最佳复合物形成取决于PF4与抗PF4 VITT抗体的化学计量比。
研究设计与样本
- 队列研究,所有送检VITT的样本均系统接受本中心半定量PF4/肝素-ELISA(光密度读数)和PF4诱导血小板活化(PIPA)试验。
- ELISA阳性而PIPA阴性的血清按1/4至1/10稀释后复检,采用逻辑回归预测每单位ELISA反应性对应PIPA阳性的概率。
主要发现
- 疑似VITT患者血清的ELISA光密度越高,PIPA反应性阳性可能性越大。
- 61份光密度>1.0且PIPA阴性的血清中,1/4至1/10稀释后27份(44.3%)转为PIPA阳性。
关键数值与推荐
- ELISA光密度>1.0且PIPA阴性的血清共61份,稀释后27份(44.3%)PIPA阳性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a prothrombotic, heparin-induced thrombocytopenia (HIT)-mimicking, adverse reaction caused by platelet-activating anti-platelet factor 4 (PF4) antibodies that occurs rarely after adenovirus vector-based COVID-19 vaccination. Strength of PF4-dependent enzyme immunoassay (EIA) reactivity-judged by optical density (OD) measurements-strongly predicts platelet-activating properties of HIT antibodies in a functional test. Whether a similar relationship holds for VITT antibodies is unknown. OBJECTIVES: To evaluate probability for positive platelet activation testing for VITT antibodies based upon EIA OD reactivity; and to investigate simple approaches to minimize false-negative platelet activation testing for VITT. METHODS: All samples referred for VITT testing were systematically evaluated by semiquantitative in-house PF4/heparin-EIA (OD readings) and PF4-induced platelet activation (PIPA) testing within a cohort study. EIA-positive sera testing PIPA-negative were retested following 1/4 to 1/10 dilution. Logistic regression was performed to predict the probability of a positive PIPA per magnitude of EIA reactivity. RESULTS: Greater EIA ODs in sera from patients with suspected VITT correlated strongly with greater likelihood of PIPA reactivity. Of 61 sera (with OD values >1.0) testing negative in the PIPA, a high proportion (27/61, 44.3%) became PIPA positive when tested at 1/4 to 1/10 dilution. CONCLUSIONS: VITT serology resembles HIT in that greater EIA OD reactivity predicts higher probability of positive testing for platelet-activating antibodies. Unlike the situation with HIT antibodies, however, diluting putative VITT serum increases probability of a positive platelet activation assay, suggesting that optimal complex formation depends on the stoichiometric ratio of PF4 and anti-PF4 VITT antibodies.
引用
- Schönborn L, Thiele T, Esefeld M, et al. Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodies. J Thromb Haemost. 2022. PMID: 36006172. doi:10.1111/jth.15862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。